GlassScriptPhysician profile
Daniel Lynn Kaler
NPI 1295745248
$1,457.22
in general payments reported to CMS, 2019-2025
10 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.89 · 2020: $652 · 2021: $11.91 · 2022: $190 · 2023: $187 · 2024: $54.83 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 3shape A/S | $450.00 | 2020 | |
| Align Technology, INC. | $196.20 | 2019-2020 | |
| Ultradent Products INC | $183.49 | 2022 | |
| 3m Company | $142.57 | 2019-2023 | Apc Flash-Free Victory Series Low Profile |
| Envista Holdings Corporation | $138.99 | 2024-2025 | Insignia, Damon |
| World Class Technology Corporation | $133.54 | 2023-2025 | Pitts21, Pitts21 Pro |
| Solventum Corporation | $94.33 | 2024-2025 | Clarity Advanced, Clarity Aligners |
| Forestadent USA, INC. | $77.76 | 2019-2023 | |
| Ormco Corporation | $22.97 | 2020-2021 | |
| American Orthodontics Corporation | $17.37 | 2022-2025 | Radiance, Empower-Ceramic, Master Series |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kaler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.